These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 16713592

  • 41. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience.
    O'Brien SF, Fearon MA, Yi QL, Fan W, Scalia V, Muntz IR, Vamvakas EC.
    Transfusion; 2007 Oct; 47(10):1809-15. PubMed ID: 17880605
    [Abstract] [Full Text] [Related]

  • 42. [Comparison of antibody responses to hepatitis B surface antigen among four recipient groups of hepatitis B vaccines that have been approved in Japan: evaluation using passive hemagglutination assay and chemiluminescent immunoassay].
    Ogata N.
    Rinsho Byori; 2009 Oct; 57(10):954-60. PubMed ID: 19928491
    [Abstract] [Full Text] [Related]

  • 43. Antibodies against HBV, HCV and HAV detected by using microparticle enzyme immunoassay in hepatitis outpatients.
    Boboş C, Spânu I, Bîlc AM.
    Roum Arch Microbiol Immunol; 2006 Oct; 65(3-4):87-92. PubMed ID: 18389722
    [Abstract] [Full Text] [Related]

  • 44. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
    Jang JS, Kim HS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Kim DJ, Lee MS, Park CK, Jeong BH, Kim YS, Jang MK.
    J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
    [Abstract] [Full Text] [Related]

  • 45. Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.
    Sukriti, Pati NT, Sethi A, Agrawal K, Agrawal K, Kumar GT, Kumar M, Kaanan AT, Sarin SK.
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1710-5. PubMed ID: 18761556
    [Abstract] [Full Text] [Related]

  • 46. Seroprevalence and risk factors of hepatitis B virus infection among health care workers at the Institute of Neurology.
    Chiarakul S, Eunumjitkul K, Vuttiopas S, Vorapimol AR, Kaewkungwal J, Poovorawan Y.
    J Med Assoc Thai; 2007 Aug; 90(8):1536-45. PubMed ID: 17926982
    [Abstract] [Full Text] [Related]

  • 47. Partial analysis of hepatitis B virus DNA from hepatocellular carcinoma showing negative hepatitis B virus surface antigen: an analysis of two Japanese cases.
    Shiota G, Oyama K, Udagawa A, Nomi T, Tanaka K, Tsutsumi A, Noguchi N, Okano J, Kishimoto Y, Kanbe T, Kishimoto H, Kawasaki H.
    Hepatogastroenterology; 2009 Aug; 56(94-95):1516-20. PubMed ID: 19950820
    [Abstract] [Full Text] [Related]

  • 48. Utilizing self-prepared ELISA plates for a cross-population study of different anti-HBe IgG subclass profiles.
    Wang L, Tsai TH, Huang CF, Ho MS, Lin DB, Ho YC, Lin SS, Wei JC, Chou MC, Yang CC.
    J Med Virol; 2007 May; 79(5):495-502. PubMed ID: 17385671
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. A simple method to measure antibody affinity against the hepatitis B surface antigen using a routine quantitative system.
    Liu H, Han Y, Wang B.
    J Virol Methods; 2011 May; 173(2):271-4. PubMed ID: 21349289
    [Abstract] [Full Text] [Related]

  • 53. Analysis of hepatitis B virus in the cerumen and otorrhea of chronic HBV-infected patients: is there a hepatitis B virus infectivity?
    Goh EK, Son BH, Kong SK, Chon KM, Cho KS.
    Otol Neurotol; 2008 Oct; 29(7):929-32. PubMed ID: 18665006
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Role of horizontal transmission in hepatitis B virus spread among household contacts in north India.
    Gupta S, Gupta R, Joshi YK, Singh S.
    Intervirology; 2008 Oct; 51(1):7-13. PubMed ID: 18309243
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations.
    Alexopoulou A, Theodorou M, Dourakis SP, Karayiannis P, Sagkana E, Papanikolopoulos K, Archimandritis AJ.
    J Viral Hepat; 2006 Sep; 13(9):591-6. PubMed ID: 16907845
    [Abstract] [Full Text] [Related]

  • 60. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.
    Nebbia G, Garcia-Diaz A, Ayliffe U, Smith C, Dervisevic S, Johnson M, Gilson R, Tedder R, Geretti AM.
    J Med Virol; 2007 Oct; 79(10):1464-71. PubMed ID: 17705185
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.